Orencia Aids Beta Cell Function (CME/CE)

(MedPage Today) -- Immune modulation with abatacept (Orencia) helped slow the decline of beta cell function in patients with recent-onset type 1 diabetes even after the treatment stopped, researchers reported.

http://www.medpagetoday.com/Endocrinology/Diabetes/43242

Source: MedPage Today Endocrinology - December 4, 2013 Category: Endocrinology Source Type: news